Page 79 - MEMORIA ANUAL 2020
P. 79

   PROGRAMA ESPAÑOL DE TRATAMIENTOS EN HEMATOLOGÍA (PETHEMA)
MEMORIA ANUAL 2020
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
• Treatment of adults with relapsed/refractory Philadelphia chromosome-positive acute lym- phoblastic leukaemia with blinatumomab in a real-world setting: results from the NEUF study. 25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Chiaretti S, Papayannidis C, Ribera JM, Bassan R, Rambaldi A, Sokolov A, Foa R, Alam N, Pezzani I, Brescianini A, Kreuzbauer G, Boissel N.
• Blinatumomab use during consolidation in adult patients with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia: preliminary results of the BLIN01 trial. 25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Ribera JM, Mercadal S, Barba P, Montesinos P, Moreno MJ, Esteve J, Martino R, Martínez P, Amigo ML, Alonso N, González-Campos J, Bernal T, Hernández-Rivas JM, Ciudad J, Barrena S, Orfao A.
• The mode of action (MOA) of the anti-CD38 monoclonal antibody (MAB) isatuximab in elderly acute myeloid leukemia (AML).
25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Zabaleta A, Jelinek T, Simoes C, Blanco L, Alameda D, Ajona D, Pérez C, Alignani D, Garate S, Lar- rayoz MJ, Calasanz MJ, Cerna L, Simicek M, Hajek R, Prósper F, Martínez-Cuadrón D, Bergua JM, Vives S, Algarra L, Tormo M, Martínez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Sanz MA, Montesinos P, San Miguel JF, Paiva B.
• Overall survival and treatment response in adults patients with acute promyelocytic leukemia. 25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Ortiz MF, Delgadillo O, Chen X, Reyes D, Serrano S, Pena A, Salazar LA, Ríos S, Luna-González M, Correa Correa M, Correa F, Cuéllar C, Sanz M, Montesinos P, Sossa C.
• FLUGAZA trial: a phase III randomized, open label study comparing azacitidine versus fludarabine and cytarabine (FLUGA scheme) in elderly patients with newly diagnosed acute myeloid leukemia.
25th Congress of the European-Hematology-Association (EHA). EHA25 virtual (JUN 10-21).
Vives Polo S, Martínez-Cuadrón D, Bergua J, Algarra L, García O, Tormo M, Martínez-Sánchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, López-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MA, Amador ML, Olave MT, Colorado M, Gascón A, Simiele A, Pérez MM, Sanz MA, Montesinos P.
79
 

















































































   77   78   79   80   81